Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
581 participants
OBSERVATIONAL
2011-11-30
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Management of Transient Loss of Consciousness and Suspected Syncope in European Emergency Departments
NCT05571254
Detecting Syncope by an Integrated Multisensor Patch-type Recorder
NCT05782699
Mechanism-based Therapy of Hypotensive Syncope
NCT06513650
SW-RCT Implementation of Canadian Syncope Risk Score Based Practice Recommendations
NCT04972071
Practical Approaches to Care in Emergency Syncope
NCT04533425
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Transient Loss of Consciousness (T-LOC)
Transient Loss of Consciousness (T-LOC). Treatment according to normal clinical practice.
Transient Loss of Consciousness (T-LOC)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transient Loss of Consciousness (T-LOC)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant women
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Angel Moya, Dr.
Role: PRINCIPAL_INVESTIGATOR
Hospital Vall d'Hebron
Jordi Tomàs, Dr.
Role: PRINCIPAL_INVESTIGATOR
H. Arnau de Vilanova de Lleida
Joan Nicolàs, Dr.
Role: PRINCIPAL_INVESTIGATOR
Parc Sanitari Sant Joan de Déu
Jordi Mercè, Dr.
Role: PRINCIPAL_INVESTIGATOR
H. Joan XXIII
Francesc Planas, Dr.
Role: PRINCIPAL_INVESTIGATOR
H. Municipal de Badalona
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SYNCAT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.